期刊文献+

经典型骨肉瘤临床诊疗专家共识 被引量:18

下载PDF
导出
摘要 骨肉瘤(Osteosarcoma)是起源于间叶组织的恶性肿瘤,以能产生骨样组织的梭形基质细胞为特征。经典型(普通型,coventionalosteosarcoma)骨肉瘤是原发于髓腔内的高度恶性肿瘤,肿瘤细胞产生骨样组织,可能是极少量。
出处 《临床肿瘤学杂志》 CAS 2012年第10期931-933,共3页 Chinese Clinical Oncology
  • 相关文献

同被引文献179

  • 1李恩惠,辛杰,张忠礼,张圣军,李湘州.Survivin与Fas在骨肉瘤中的表达、临床意义及相关性[J].中国矫形外科杂志,2013,21(23):2383-2388. 被引量:2
  • 2王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:623
  • 3赵红兵,张喜凤.CT引导下穿刺活检诊断软骨肉瘤25例[J].新乡医学院学报,2007,24(2):177-178. 被引量:1
  • 4Yang YK, Niu XH, Zhang Q, et al. The efficacy of abraxane on osteosarcoma xenografts in nude mice and expression of secreted protein, acidic and rich in cysteine[J]. Am J Med Sci, 2012, 344 ( 3 ) : 199 - 205.
  • 5The ESMO/European Sarcoma Network Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol, 2012, 23 (Suppl 7) : 100 - 109.
  • 6Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors [ J ]. Bull Cancer, 2000, 87 (12) : 881 - 886.
  • 7Mori K, Ando K, Heymann D. Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against os- teosarcoma pulmonary metastases [ J ]. Expert Rev Anticancer T- her, 2008, 8(2):151 -159.
  • 8Desai N, Trieu V, Damascelli B, et al. SPARC expression cor- relates with tumor response to albumin-bound paclitaxel in head and neck cancer patients [ J ]. Transl Oncol, 2009, 2 (2) : 59 - 64.
  • 9Ackland SP, Bull JM, Boyle FM,et al. Nab-Paclitaxel: a bright new SPARC in taxane therapy of cancer[ J]. Asia-Pacific J Clin Oncol, 2009, 5(3) :147 - 150.
  • 10Chakravarthi SS, De S, Miller DW, et al. Comparison of anti- tumor efficacy of paclitaxel delivered in nano and microparticles [J]. IntJPham~,2010, 383(112) :37 -44.

引证文献18

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部